coffman robert (32 Ergebnisse)

Paperback. Zustand: As New. APPEARS UNREAD. Paperback. Covers show minimal shelving wear, otherwise an UNBLEMISHED copy.; 100% Satisfaction Guaranteed! Ships same or next business day!

Zustand: Good. Former library book; may include library markings. Used book that is in clean, average condition without any missing pages.

gebunden. Seiten 141-317 570 gr. sehr guter Zustand, Einband leicht berieben.

Zustand: New. pp. 372 Illus.

Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,550grams, ISBN:9783764358839.

Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. Clean from markings In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,550grams, ISBN:9783764358839.

Zustand: New. pp. 148.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. Editor(s): Coffman, Robert L.; Romagnani, Sergio. Series: Current Topics in Microbiology and Immunology. Num Pages: 159 pages, 8 black & white illustrations, 10 black & white tables. BIC Classification: MJCM; PSD; PSG. Category: (G) General (US: Trade). Dimension: 235 x 155 x 8. Weight in Grams: 260. . 1998. Softcover reprint of the original 1st ed. 1999. Paperback. . . . . Books ship from the US and Ireland.

Zustand: New. pp. xi + 141.

Zustand: Sehr gut. Auflage: 2000. 141 Seiten kaum benutzt aus einer Firmenbibliothek Sprache: Englisch Gewicht in Gramm: 469 22,9 x 16,5 x 1,3 cm, Gebundene Ausgabe.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - It has been 12 years since the first proposal was made to sub divide mouse CD4 I T cell clones into Th I and Th2 subsets, based on their differences in cytokine production, and 7 years since the first clear demonstration of a similar dichotomy among human T cell clones. In the ensuing period, it has been realized that inappropriate development of Th I or Th2 responses are important features of many immunological and infectious dis eases. Perhaps the first group of diseases to be understood in terms of preferential Th subset activation were allergic diseases (see PARRONC'HI et aI. , this volume). Several of the major, co ordinately regulated, features of allergy, including IgE, eosino philia and mastocytosis, were found to be stimulated by the T- specific cytokines I L-4 and IL-5 and inhibited by the Th I cyto kine, IFN-. This suggested that the presence and severity of al lergic responses reflected the relative numbers of Th I and Th2 cells specific for the offending allergen. Similarly, the very dif ferent consequences of protective Th I and nonprotective Th2 responses to a number of intracellular pathogens have been re cognized for some time (see TRINCHIERI and SCOTI, and COFF MAN et aI. , this volume).

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past ten years, a number of cytokines and growth factors haveproven to be as effective therapeutics. While these products havecertainly established recombinant biologics as a major pharmaceuticalgrowth sector, the continued interest in this class of drugs arises fromthe fact that today we have a far better understanding of the humanimmune response, both at a cellular and molecular level.This has resulted in a more methodical characterisation of these factorswhich has given clinical researchers an opportunity to plan Phase 1clinical trials that can provide substantial information on the activityof the cytokine in humans. Currently, a great deal of effort is alsobeing channelled into identifying cytokines from the various DNAdatabases.Our major objective for this book is to profile cytokines that have beenrecently identified. The therapeutic potential of these cytokines basedon their known properties will be discussed by the authors. The main aimof this book is to provide.

Zustand: New.

Gebunden. Zustand: New.

Zustand: New. pp. 196 20 Illus.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Buch. Zustand: Neu. Neuware -We are celebrating this year the hundred years¿ anniversary of allergen-specific immunotherapy. In 1911 Leonard Noon published his seminal work ¿Prophylactic inoculation against hay fever¿ describing his attempts to achieve active immunity against ¿grass pollen toxin¿ by administering increasing doses of grass pollen extract before the grass pollen season to allergic patients. Although it was unknown at that time that allergy represents an immunological hypersensitivity disease, the treatment was effective and many observations made by Noon remained valid until today. Today allergen-specific immunotherapy is well established as the only allergen-specific and disease-modifying treatment for IgE-mediated allergies and has long-lasting effects. In fact, more than 25% of the population suffer from IgE-mediated allergies which therefore represent a major health burden of our society, particularly because untreated allergy often progresses to severe disabling forms of disease, such as asthma and sometimes kills sensitized people through anaphylaxis.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 196 pp. Englisch.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - We are celebrating this year the hundred years anniversary of allergen-specific immunotherapy. In 1911 Leonard Noon published his seminal work 'Prophylactic inoculation against hay fever' describing his attempts to achieve active immunity against 'grass pollen toxin' by administering increasing doses of grass pollen extract before the grass pollen season to allergic patients. Although it was unknown at that time that allergy represents an immunological hypersensitivity disease, the treatment was effective and many observations made by Noon remained valid until today. Today allergen-specific immunotherapy is well established as the only allergen-specific and disease-modifying treatment for IgE-mediated allergies and has long-lasting effects. In fact, more than 25% of the population suffer from IgE-mediated allergies which therefore represent a major health burden of our society, particularly because untreated allergy often progresses to severe disabling forms of disease, such as asthma and sometimes kills sensitized people through anaphylaxis.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - We are celebrating this year the hundred years anniversary of allergen-specific immunotherapy. In 1911 Leonard Noon published his seminal work 'Prophylactic inoculation against hay fever' describing his attempts to achieve active immunity against 'grass pollen toxin' by administering increasing doses of grass pollen extract before the grass pollen season to allergic patients. Although it was unknown at that time that allergy represents an immunological hypersensitivity disease, the treatment was effective and many observations made by Noon remained valid until today. Today allergen-specific immunotherapy is well established as the only allergen-specific and disease-modifying treatment for IgE-mediated allergies and has long-lasting effects. In fact, more than 25% of the population suffer from IgE-mediated allergies which therefore represent a major health burden of our society, particularly because untreated allergy often progresses to severe disabling forms of disease, such as asthma and sometimes kills sensitized people through anaphylaxis.

4°, original cloth binding. 1. ed. With numerous illustrations in the text and on plates, 598 p. Well founded edition. Very fine copy. Sprache: Englisch Gewicht in Gramm: 0.

Hardcover. Zustand: Brand New. 2011 edition. 170 pages. 9.25x6.25x0.50 inches. In Stock.

Buch. Zustand: Neu. Neuware -Over the past ten years, a number of cytokines and growth factors haveproven to be as effective therapeutics. While these products havecertainly established recombinant biologics as a major pharmaceuticalgrowth sector, the continued interest in this class of drugs arises fromthe fact that today we have a far better understanding of the humanimmune response, both at a cellular and molecular level.This has resulted in a more methodical characterisation of these factorswhich has given clinical researchers an opportunity to plan Phase 1clinical trials that can provide substantial information on the activityof the cytokine in humans. Currently, a great deal of effort is alsobeing channelled into identifying cytokines from the various DNAdatabases.Our major objective for this book is to profile cytokines that have beenrecently identified. The therapeutic potential of these cytokines basedon their known properties will be discussed by the authors. The main aimof this book is to provide.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 156 pp. Englisch.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past ten years, a number of cytokines and growth factors haveproven to be as effective therapeutics. While these products havecertainly established recombinant biologics as a major pharmaceuticalgrowth sector, the continued interest in this class of drugs arises fromthe fact that today we have a far better understanding of the humanimmune response, both at a cellular and molecular level.This has resulted in a more methodical characterisation of these factorswhich has given clinical researchers an opportunity to plan Phase 1clinical trials that can provide substantial information on the activityof the cytokine in humans. Currently, a great deal of effort is alsobeing channelled into identifying cytokines from the various DNAdatabases.Our major objective for this book is to profile cytokines that have beenrecently identified. The therapeutic potential of these cytokines basedon their known properties will be discussed by the authors. The main aimof this book is to provide.

Hardcover. Zustand: Brand New. 2000 edition. 141 pages. 9.00x6.50x0.50 inches. In Stock.

Zustand: New. Etiology and Pathogenesis of Atherosclerosis Markus C. Stuehlinger and Philip S. Tsao The Epidemiology and Natural History of Peripheral Arterial Disease Lisa M. Bordeaux, Laura M. Reich, and Alan T. Hirsch Clinical Evaluation of Intermittent Claudication .

Zustand: New. 2000. Hardcover. . . . . . Books ship from the US and Ireland.

Zustand: New. Editor(s): Coffman, Jay D.; Eberhardt, Robert T. Series: Contemporary Cardiology. Num Pages: 368 pages, biography. BIC Classification: MJD. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 19. Weight in Grams: 706. . 2010. 1st ed. Softcover of orig. ed. 2003. Paperback. . . . . Books ship from the US and Ireland.